Kane Biotech Inc. (CVE:KNE) Director Buys C$11,250.00 in Stock September 18, 2024 by InsiderTrades.com Share Kane Biotech Inc. (CVE:KNE - Get Free Report) Director Robert Huizinga acquired 90,000 shares of the stock in a transaction dated Friday, September 13th. The shares were purchased at an average price of C$0.13 per share, for a total transaction of C$11,250.00. Kane Biotech Stock PerformanceKane Biotech stock opened at C$0.13 on Wednesday. The stock has a 50-day simple moving average of C$0.14 and a 200 day simple moving average of C$0.13. The stock has a market capitalization of C$17.23 million, a P/E ratio of -4.33 and a beta of 0.54. The company has a debt-to-equity ratio of 1,164.24, a quick ratio of 0.39 and a current ratio of 0.82. Kane Biotech Inc. has a 52 week low of C$0.05 and a 52 week high of C$0.17. Kane Biotech Company Profile (Get Free Report)Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.Featured StoriesFive stocks we like better than Kane BiotechHow to Evaluate a Stock Before Buying Galmed Pharmaceuticals Surges 400%: What's Behind the Explosion?Health Care Stocks Explained: Why You Might Want to InvestGold Hits New All-Time Highs: 3 Stocks to Ride the SurgeWhy Are These Companies Considered Blue Chips?Intel: Why It's Time to Reconsider This Beaten-Down ChipmakerThis instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected]. Insider Buying or Selling at Kane Biotech? Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Kane Biotech and related companies. More From MarketBeatBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | Sponsored7 Travel Stocks That Still Have Room to RunThere's good news and bad news for those interested in investing in travel stocks in 2024. A report from Skift...MarketBeatBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | Sponsored15 Stocks Institutional Investors Are Selling NowHedge funds, endowments, and other institutional investors have been selling shares of these 15 stocks in the ...MarketBeatBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | Sponsored7 Consumer Discretionary Stocks That Will Heat Up with Rate Cuts As the second quarter earnings season ends, a recurring theme for many companies that rely on the discretionar...MarketBeatChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | Sponsored7 Gene Editing Stocks Offering Transformational ChangeInvestors are talking about the impact that artificial intelligence (AI) can have on their portfolios. But the...MarketBeat Free Insider Buying and Selling Newsletter Enter your email address below to receive InsiderTrades.com's daily insider buying and selling report. From Our PartnersBiden's Executive Order, Dems Digital Money Legislation, First Step ToDonald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans...Monetary Gold | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredBiden to Launch “FedNOW” [Move Your Money Now]Earlier this year President Biden signed the death warrant for America… Executive Order 14067 will essentia...Priority Gold | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredThis diversified cannabis pioneer could make huge moves soonThe cannabis industry seems deeply saturated, so how do you know where to best invest your money? Let’s start ...Greenlane | Sponsored Most Read This Month3 Small Cap Stocks That Insiders Are BuyingMatador Resources Insiders Keep Buying Its Stock, Should You?This Is the Top Large-Cap Stock Insiders Are BuyingMGM Insiders Bet Big on Its Undervalued StockMark Zuckerberg Sells 16,702 Shares of Meta Platforms, Inc. (NASDAQ:META) StockJennifer Newstead Sells 905 Shares of Meta Platforms, Inc. (NASDAQ:META) StockAlphabet Inc. (NASDAQ:GOOGL) CEO Sells $3,772,350.00 in StockTop Holdco B.V. Bitfury Sells 1,901,112 Shares of Cipher Mining Inc. (NASDAQ:CIFR) StockRecent ArticlesBlackbaud, Inc. (NASDAQ:BLKB) SVP Jon W. Olson Sells 2,000 SharesInsider Selling: Cadence Design Systems, Inc. (NASDAQ:CDNS) SVP Sells 659 Shares of StockBradley Lee Soultz Buys 5,000 Shares of WillScot Mobile Mini Holdings Corp. (NASDAQ:WSC) StockCiena Co. (NYSE:CIEN) SVP David M. Rothenstein Sells 3,500 SharesInsider Buying: Canadian National Railway (TSE:CNR) Director Acquires 1,230 Shares of StockDonnelley Financial Solutions, Inc. (NYSE:DFIN) CEO Sells $201,756.43 in StockInsider Selling: Prairie Operating Co. (NASDAQ:PROP) Major Shareholder Sells 68,134 Shares of StockPalantir Technologies Inc. (NYSE:PLTR) Director Lauren Elaina Friedman Stat Sells 6,000 Shares
